%0 Journal Article
%9 ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES
%A Boulle, C.
%A Njamnshi, A. K.
%A Dema, F.
%A Mengnjo, M. K.
%A Fodjo, J. N. S.
%A Bissek, Aczk
%A Suykerbuyk, P.
%A Lenou-Nanga, C. G.
%A Nana-Djeunga, H. C.
%A Kamgno, J.
%A Chesnais, Cedric
%A Boussinesq, Michel
%A Colebunders, R.
%T Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
%D 2019
%L fdi:010075502
%G ENG
%J Parasites and Vectors
%@ 1756-3305
%K Cameroon ; Epilepsy ; Onchocerciasis ; Community study
%K CAMEROUN
%M ISI:000462195900001
%P art. 114 [13 ]
%R 10.1186/s13071-019-3345-7
%U https://www.documentation.ird.fr/hor/fdi:010075502
%> https://horizon.documentation.ird.fr/exl-doc/pleins_textes/divers19-04/010075502.pdf
%V 12
%W Horizon (IRD)
%X BackgroundSurveys conducted in 1991-1992 in the Mbam Valley (Cameroon) revealed that onchocerciasis was highly endemic, with community microfilarial loads (CMFL)>100 microfilariae/snip in some villages. Also in 1991-1992, a survey of suspected cases of epilepsy (SCE) found 746 SCE using a questionnaire administered to individuals identified by key informants, with prevalences reaching 13.6% in some communities. From 1998, annual community-directed treatment with ivermectin (CDTI) was implemented to control onchocerciasis. In 2017, a door-to-door household survey was conducted in three of the villages visited in 1991-1992, using a standardized 5-item epilepsy screening questionnaire.ResultsIn 2017, a total of 2286 individuals living in 324 households were screened (582 in Bayomen, 553 in Ngongol and 1151 in Nyamongo) and 112 SCE were identified (4.9%). Neurologists examined 92 of these SCE and confirmed the diagnosis of epilepsy for 81 of them (3.5%). Between the surveys in 1991-1992 and 2017, the prevalence of SCE decreased from 13.6% to 2.5% in Bayomen (P=0.001), from 8.7% to 6.6% in Ngongol (P=0.205) and from 6.4% to 5.4% in Nyamongo (P=0.282). The median age of SCE shifted from 20 (IQR: 12-23) to 29years (IQR: 18-33; P=0.018) in Bayomen, from 16 (IQR: 12-21) to 26years (IQR: 21-39; P<0.001) in Ngongol and from 16 (IQR: 13-19) to 24years (IQR: 19-32; P<0.001) in Nyamongo. The proportions of SCE aged <10, 10-19, 20-29 and 30years shifted from 9.5, 58.3, 25.0 and 7.1% in 1991-1992 to 2.7, 20.5, 39.3 and 37.5% in 2017, respectively.ConclusionsSCE prevalence decreased overall between 1991-1992 and 2017. The age shift observed is probably due to a decrease in the number of new cases of epilepsy resulting from the dramatic reduction of Onchocerca volvulus transmission after 19years of CDTI.
%$ 052 ; 050